In association with

Remaining advisers must pay for others’ insolvency

Philip Ryley

Forced retirement can be justified

Home > Investments > Equities

Finsbury sees stable biotech yields ahead

Pharmaceutical trust manager expects positive changes and less volatility ahead

Article Tools

visible-status-Standard story-url-IA p13 090309 Finsbury.xml

Related Special Reports

  • Multi-Manager - May 2012

    Some wonder whether multi-manager funds are worth the money, and therefore the performance of the sector comes under close scrutiny

  • Multi-Manager - May 2012

    Some wonder whether multi-manager funds are worth the money, and therefore the performance of the sector comes under close scrutiny

  • Mid-Year Monitor - May 2012

    This annual special report examines the key issues likely to affect markets in the second half of 2012

See all reports
More on FTAdviser
FTA jobs